| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inhibitor of Differentiation Proteins | 19 | 2017 | 28 | 7.430 |
Why?
|
| Prostatic Neoplasms | 23 | 2017 | 935 | 4.530 |
Why?
|
| Sertoli Cells | 15 | 2005 | 42 | 2.510 |
Why?
|
| Prostate | 6 | 2016 | 154 | 1.950 |
Why?
|
| Receptors, Androgen | 7 | 2017 | 126 | 1.820 |
Why?
|
| Follicle Stimulating Hormone | 11 | 2004 | 43 | 1.710 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 8 | 2019 | 9 | 1.640 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2017 | 807 | 1.490 |
Why?
|
| Promoter Regions, Genetic | 15 | 2014 | 515 | 1.490 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 5 | 2019 | 80 | 1.370 |
Why?
|
| Apoptosis | 12 | 2017 | 1398 | 1.320 |
Why?
|
| Cell Line, Tumor | 22 | 2020 | 2231 | 1.270 |
Why?
|
| Neoplasm Proteins | 5 | 2017 | 213 | 1.200 |
Why?
|
| Transcription Factors | 9 | 2013 | 681 | 1.140 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 5 | 2015 | 7 | 1.130 |
Why?
|
| Helix-Loop-Helix Motifs | 8 | 2005 | 13 | 1.120 |
Why?
|
| Transferrin | 10 | 2002 | 40 | 1.080 |
Why?
|
| Antibiotics, Antineoplastic | 3 | 2018 | 44 | 1.030 |
Why?
|
| Doxorubicin | 3 | 2018 | 84 | 1.000 |
Why?
|
| Lysine | 2 | 2017 | 113 | 1.000 |
Why?
|
| Male | 50 | 2020 | 20025 | 0.970 |
Why?
|
| Cell Differentiation | 16 | 2014 | 587 | 0.960 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2017 | 213 | 0.950 |
Why?
|
| DNA-Binding Proteins | 9 | 2012 | 539 | 0.930 |
Why?
|
| Transcription, Genetic | 5 | 2015 | 578 | 0.770 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2012 | 63 | 0.750 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2017 | 259 | 0.740 |
Why?
|
| Epithelial Cells | 5 | 2012 | 384 | 0.730 |
Why?
|
| Tacrolimus Binding Proteins | 2 | 2017 | 43 | 0.700 |
Why?
|
| Cell Cycle | 5 | 2014 | 326 | 0.690 |
Why?
|
| Gene Expression Regulation | 10 | 2010 | 1015 | 0.680 |
Why?
|
| Gene Silencing | 4 | 2014 | 151 | 0.680 |
Why?
|
| Taxoids | 2 | 2016 | 37 | 0.630 |
Why?
|
| Cell Proliferation | 11 | 2019 | 1198 | 0.620 |
Why?
|
| Animals | 33 | 2020 | 15081 | 0.610 |
Why?
|
| Humans | 39 | 2020 | 37093 | 0.600 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2014 | 194 | 0.600 |
Why?
|
| Transfection | 10 | 2014 | 523 | 0.590 |
Why?
|
| Rats | 23 | 2020 | 3483 | 0.590 |
Why?
|
| Repressor Proteins | 3 | 2005 | 249 | 0.590 |
Why?
|
| Testis | 5 | 2014 | 187 | 0.570 |
Why?
|
| Nanoparticles | 3 | 2020 | 318 | 0.540 |
Why?
|
| Cell Division | 2 | 2014 | 307 | 0.530 |
Why?
|
| Growth and Development | 1 | 2014 | 8 | 0.500 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2014 | 767 | 0.500 |
Why?
|
| Testosterone | 3 | 2014 | 193 | 0.470 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2013 | 10 | 0.470 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 9 | 2009 | 623 | 0.460 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2013 | 222 | 0.460 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2013 | 12 | 0.450 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 54 | 0.440 |
Why?
|
| Histones | 1 | 2014 | 190 | 0.440 |
Why?
|
| Interleukin-6 | 1 | 2014 | 153 | 0.440 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2012 | 21 | 0.430 |
Why?
|
| Drug Carriers | 3 | 2020 | 125 | 0.430 |
Why?
|
| Homeodomain Proteins | 1 | 2013 | 132 | 0.420 |
Why?
|
| Inflammation | 2 | 2008 | 618 | 0.420 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 251 | 0.410 |
Why?
|
| Androgens | 3 | 2010 | 89 | 0.410 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2011 | 6 | 0.400 |
Why?
|
| Molecular Sequence Data | 10 | 2014 | 1568 | 0.390 |
Why?
|
| Base Sequence | 10 | 2005 | 997 | 0.360 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2001 | 54 | 0.360 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2010 | 306 | 0.360 |
Why?
|
| Mice, Nude | 4 | 2019 | 337 | 0.360 |
Why?
|
| Small Molecule Libraries | 2 | 2020 | 45 | 0.340 |
Why?
|
| Calcitonin | 1 | 2008 | 5 | 0.330 |
Why?
|
| Cell Survival | 4 | 2018 | 864 | 0.330 |
Why?
|
| RNA, Messenger | 7 | 2013 | 1207 | 0.330 |
Why?
|
| Mice | 9 | 2019 | 5913 | 0.320 |
Why?
|
| Neoplasm Invasiveness | 3 | 2016 | 251 | 0.320 |
Why?
|
| RNA-Binding Proteins | 2 | 2013 | 146 | 0.310 |
Why?
|
| Neoplasm Metastasis | 1 | 2008 | 219 | 0.290 |
Why?
|
| Mice, SCID | 2 | 2017 | 150 | 0.280 |
Why?
|
| Cells, Cultured | 10 | 2009 | 1518 | 0.280 |
Why?
|
| Chromosomal Instability | 1 | 2006 | 22 | 0.280 |
Why?
|
| Polyesters | 2 | 2016 | 25 | 0.270 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2012 | 55 | 0.270 |
Why?
|
| Polysaccharides | 2 | 2016 | 58 | 0.260 |
Why?
|
| Tumor Burden | 2 | 2016 | 77 | 0.260 |
Why?
|
| Acetylation | 2 | 2017 | 98 | 0.260 |
Why?
|
| Case-Control Studies | 3 | 2014 | 1130 | 0.260 |
Why?
|
| DNA Methylation | 3 | 2014 | 325 | 0.250 |
Why?
|
| Neoplasms | 1 | 2014 | 1103 | 0.240 |
Why?
|
| RNA, Small Interfering | 4 | 2012 | 409 | 0.240 |
Why?
|
| RNA Interference | 2 | 2016 | 243 | 0.230 |
Why?
|
| Oligonucleotides, Antisense | 4 | 2005 | 39 | 0.220 |
Why?
|
| Response Elements | 2 | 2001 | 56 | 0.220 |
Why?
|
| Gene Expression | 5 | 2013 | 674 | 0.220 |
Why?
|
| Phenotype | 2 | 2017 | 689 | 0.210 |
Why?
|
| Zinc Fingers | 1 | 2002 | 26 | 0.210 |
Why?
|
| Nuclear Proteins | 2 | 2001 | 307 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 1999 | 82 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2014 | 1618 | 0.200 |
Why?
|
| Mice, Knockout | 2 | 2014 | 933 | 0.190 |
Why?
|
| Amino Acid Sequence | 3 | 2014 | 1180 | 0.190 |
Why?
|
| Docosahexaenoic Acids | 1 | 2020 | 18 | 0.190 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2020 | 23 | 0.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2002 | 187 | 0.190 |
Why?
|
| Mutation | 2 | 2017 | 1095 | 0.180 |
Why?
|
| Titanium | 1 | 2020 | 36 | 0.180 |
Why?
|
| Trans-Activators | 1 | 2001 | 174 | 0.180 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2000 | 78 | 0.180 |
Why?
|
| Gene Expression Profiling | 3 | 2010 | 626 | 0.180 |
Why?
|
| Carrier Proteins | 1 | 2002 | 305 | 0.180 |
Why?
|
| Proteins | 2 | 2009 | 369 | 0.170 |
Why?
|
| Light | 1 | 2020 | 187 | 0.170 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 61 | 0.170 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2020 | 47 | 0.170 |
Why?
|
| Signal Transduction | 1 | 2008 | 1908 | 0.170 |
Why?
|
| Genes, fos | 2 | 1996 | 14 | 0.170 |
Why?
|
| Consensus Sequence | 1 | 1999 | 24 | 0.170 |
Why?
|
| Sepharose | 1 | 2018 | 15 | 0.170 |
Why?
|
| Blotting, Western | 3 | 2007 | 859 | 0.170 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2010 | 31 | 0.160 |
Why?
|
| Down-Regulation | 2 | 2012 | 435 | 0.160 |
Why?
|
| Cell Growth Processes | 2 | 2009 | 41 | 0.160 |
Why?
|
| Delayed-Action Preparations | 1 | 2018 | 60 | 0.160 |
Why?
|
| Neovascularization, Pathologic | 1 | 2019 | 127 | 0.160 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 145 | 0.160 |
Why?
|
| Hydrogels | 1 | 2018 | 37 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2013 | 628 | 0.160 |
Why?
|
| Ulva | 1 | 2018 | 7 | 0.160 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 893 | 0.160 |
Why?
|
| Ferrous Compounds | 1 | 2018 | 20 | 0.160 |
Why?
|
| Trophoblasts | 3 | 1992 | 24 | 0.160 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 190 | 0.160 |
Why?
|
| Nanocomposites | 1 | 2018 | 19 | 0.160 |
Why?
|
| Cyclic AMP | 4 | 2001 | 131 | 0.150 |
Why?
|
| Water Purification | 1 | 2018 | 28 | 0.150 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2017 | 11 | 0.150 |
Why?
|
| Anilides | 1 | 2017 | 28 | 0.150 |
Why?
|
| Graphite | 1 | 2018 | 51 | 0.150 |
Why?
|
| Cyclohexanes | 1 | 2017 | 30 | 0.150 |
Why?
|
| Cloning, Molecular | 3 | 2004 | 325 | 0.140 |
Why?
|
| Cell Shape | 2 | 2013 | 35 | 0.140 |
Why?
|
| Protein Isoforms | 2 | 2007 | 130 | 0.140 |
Why?
|
| Chorionic Gonadotropin | 3 | 1992 | 15 | 0.140 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 172 | 0.140 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 173 | 0.140 |
Why?
|
| Blotting, Northern | 3 | 2002 | 150 | 0.140 |
Why?
|
| Retrospective Studies | 2 | 2013 | 2026 | 0.140 |
Why?
|
| Protein Transport | 1 | 2017 | 302 | 0.130 |
Why?
|
| Water Pollutants, Chemical | 1 | 2018 | 164 | 0.130 |
Why?
|
| Intracellular Space | 1 | 2015 | 35 | 0.130 |
Why?
|
| Progesterone | 2 | 1992 | 113 | 0.130 |
Why?
|
| Cell Nucleus | 1 | 2017 | 366 | 0.130 |
Why?
|
| Sequence Homology | 1 | 2014 | 34 | 0.130 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 28 | 0.130 |
Why?
|
| Genetic Loci | 1 | 2015 | 90 | 0.120 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 122 | 0.120 |
Why?
|
| Seminiferous Epithelium | 1 | 2014 | 5 | 0.120 |
Why?
|
| Recombinant Proteins | 3 | 2013 | 515 | 0.120 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 113 | 0.120 |
Why?
|
| Tubulin | 1 | 2014 | 88 | 0.120 |
Why?
|
| Nandrolone | 2 | 1990 | 6 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2013 | 1 | 0.120 |
Why?
|
| E2F1 Transcription Factor | 1 | 2013 | 17 | 0.120 |
Why?
|
| Protein Binding | 1 | 2017 | 972 | 0.120 |
Why?
|
| Vimentin | 1 | 2013 | 37 | 0.110 |
Why?
|
| Fertility | 2 | 1990 | 59 | 0.110 |
Why?
|
| Spermatids | 1 | 2013 | 42 | 0.110 |
Why?
|
| Spermatogonia | 1 | 2014 | 56 | 0.110 |
Why?
|
| Antigens, CD | 1 | 2013 | 121 | 0.110 |
Why?
|
| Cadherins | 1 | 2013 | 90 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 2 | 2019 | 661 | 0.110 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 114 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 219 | 0.100 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2012 | 93 | 0.100 |
Why?
|
| Phylogeny | 1 | 2014 | 644 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 286 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2013 | 534 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 269 | 0.100 |
Why?
|
| DNA, Complementary | 2 | 2004 | 191 | 0.100 |
Why?
|
| Genitalia, Male | 1 | 1990 | 13 | 0.090 |
Why?
|
| Contraceptive Agents, Male | 1 | 1990 | 3 | 0.090 |
Why?
|
| Hormones | 1 | 1990 | 55 | 0.090 |
Why?
|
| Agar | 1 | 2010 | 8 | 0.090 |
Why?
|
| Colony-Forming Units Assay | 1 | 2010 | 12 | 0.090 |
Why?
|
| Karyotyping | 1 | 2010 | 47 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2013 | 928 | 0.090 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 91 | 0.090 |
Why?
|
| Logistic Models | 1 | 2013 | 923 | 0.090 |
Why?
|
| Telomerase | 1 | 2010 | 44 | 0.090 |
Why?
|
| Genomics | 1 | 2011 | 223 | 0.090 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 3 | 1999 | 24 | 0.090 |
Why?
|
| Cell Line | 2 | 2019 | 1354 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 2 | 2004 | 474 | 0.090 |
Why?
|
| Adsorption | 2 | 2020 | 68 | 0.090 |
Why?
|
| Bucladesine | 2 | 2001 | 8 | 0.080 |
Why?
|
| Phytosterols | 1 | 2009 | 3 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 120 | 0.080 |
Why?
|
| Prostatic Hyperplasia | 1 | 2009 | 34 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 803 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 2 | 2008 | 502 | 0.080 |
Why?
|
| Genes, Reporter | 2 | 2002 | 136 | 0.080 |
Why?
|
| Cell Movement | 1 | 2012 | 571 | 0.080 |
Why?
|
| RNA, Untranslated | 1 | 2009 | 42 | 0.080 |
Why?
|
| Receptors, Calcitonin | 1 | 2008 | 3 | 0.080 |
Why?
|
| RNA, Catalytic | 1 | 2008 | 5 | 0.080 |
Why?
|
| Dependovirus | 1 | 2008 | 12 | 0.080 |
Why?
|
| Genotype | 1 | 2011 | 730 | 0.080 |
Why?
|
| Flow Cytometry | 2 | 2009 | 399 | 0.080 |
Why?
|
| Adult | 2 | 2014 | 11712 | 0.080 |
Why?
|
| Binding Sites | 3 | 2000 | 651 | 0.080 |
Why?
|
| Middle Aged | 2 | 2014 | 10129 | 0.080 |
Why?
|
| Kinetics | 2 | 2018 | 708 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 2379 | 0.080 |
Why?
|
| Computational Biology | 1 | 2010 | 293 | 0.080 |
Why?
|
| Cell Adhesion | 1 | 2008 | 212 | 0.080 |
Why?
|
| Cholesterol | 1 | 2009 | 205 | 0.080 |
Why?
|
| DNA | 3 | 2000 | 574 | 0.070 |
Why?
|
| Lipoproteins, LDL | 2 | 2020 | 62 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2006 | 7 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2006 | 11 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2006 | 10 | 0.070 |
Why?
|
| Loss of Heterozygosity | 1 | 2006 | 19 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2006 | 12 | 0.070 |
Why?
|
| Genes, Neoplasm | 1 | 2006 | 13 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2006 | 27 | 0.070 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 617 | 0.070 |
Why?
|
| Genomic Instability | 1 | 2006 | 38 | 0.070 |
Why?
|
| Epithelium | 1 | 2006 | 79 | 0.070 |
Why?
|
| Metribolone | 1 | 2005 | 3 | 0.070 |
Why?
|
| Expressed Sequence Tags | 1 | 2005 | 27 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 142 | 0.060 |
Why?
|
| RNA | 2 | 2009 | 241 | 0.050 |
Why?
|
| Adolescent | 1 | 2014 | 5363 | 0.050 |
Why?
|
| Spermatogenesis | 2 | 2014 | 155 | 0.050 |
Why?
|
| RNA, Antisense | 1 | 2002 | 17 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2002 | 27 | 0.050 |
Why?
|
| Gene Library | 1 | 2002 | 57 | 0.050 |
Why?
|
| Aged | 1 | 2014 | 6741 | 0.050 |
Why?
|
| Immunosorbent Techniques | 1 | 2001 | 3 | 0.050 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2001 | 11 | 0.050 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2020 | 1 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2001 | 73 | 0.050 |
Why?
|
| 14-3-3 Proteins | 1 | 2000 | 22 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2020 | 207 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2000 | 74 | 0.050 |
Why?
|
| Catalysis | 1 | 2020 | 179 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2000 | 76 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2000 | 265 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2019 | 35 | 0.040 |
Why?
|
| Serum Response Factor | 1 | 1999 | 10 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 1039 | 0.040 |
Why?
|
| Oligonucleotides | 1 | 1999 | 49 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1999 | 49 | 0.040 |
Why?
|
| Protein Folding | 1 | 2020 | 127 | 0.040 |
Why?
|
| Seaweed | 1 | 2018 | 11 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 201 | 0.040 |
Why?
|
| Anions | 1 | 2018 | 39 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2018 | 51 | 0.040 |
Why?
|
| Vero Cells | 1 | 2018 | 93 | 0.040 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 1998 | 2 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2018 | 129 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 1998 | 31 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1998 | 29 | 0.040 |
Why?
|
| Drug Compounding | 1 | 2018 | 76 | 0.040 |
Why?
|
| Chromium | 1 | 2018 | 27 | 0.040 |
Why?
|
| Bronchi | 1 | 1998 | 46 | 0.040 |
Why?
|
| Coloring Agents | 1 | 2018 | 51 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2020 | 492 | 0.040 |
Why?
|
| Liver | 1 | 2020 | 479 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 1998 | 136 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 364 | 0.040 |
Why?
|
| Female | 6 | 2019 | 20969 | 0.040 |
Why?
|
| TCF Transcription Factors | 1 | 1997 | 15 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1998 | 172 | 0.040 |
Why?
|
| Lead | 1 | 2018 | 93 | 0.040 |
Why?
|
| Dimerization | 1 | 1997 | 112 | 0.040 |
Why?
|
| Testicular Hormones | 1 | 1995 | 1 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 1609 | 0.030 |
Why?
|
| Receptor, erbB-3 | 1 | 2014 | 12 | 0.030 |
Why?
|
| Sperm Count | 2 | 1990 | 25 | 0.030 |
Why?
|
| Nanotechnology | 1 | 2015 | 153 | 0.030 |
Why?
|
| Sperm Motility | 2 | 1990 | 38 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 1998 | 358 | 0.030 |
Why?
|
| Sperm Maturation | 1 | 2013 | 2 | 0.030 |
Why?
|
| Cell Separation | 1 | 2014 | 93 | 0.030 |
Why?
|
| Rats, Transgenic | 1 | 2013 | 27 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2013 | 29 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2013 | 29 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2013 | 78 | 0.030 |
Why?
|
| Receptors, LHRH | 1 | 1992 | 2 | 0.030 |
Why?
|
| Growth Inhibitors | 1 | 2012 | 26 | 0.030 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1992 | 33 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 208 | 0.030 |
Why?
|
| Secretory Rate | 1 | 1992 | 2 | 0.030 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1992 | 13 | 0.030 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 1992 | 7 | 0.030 |
Why?
|
| Culture Techniques | 1 | 1992 | 24 | 0.030 |
Why?
|
| Giant Cells | 1 | 1992 | 13 | 0.030 |
Why?
|
| Proteome | 1 | 2013 | 144 | 0.030 |
Why?
|
| Proteomics | 1 | 2013 | 325 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 1990 | 63 | 0.020 |
Why?
|
| Estradiol | 1 | 1992 | 262 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 1990 | 14 | 0.020 |
Why?
|
| Progestins | 1 | 1990 | 12 | 0.020 |
Why?
|
| Random Allocation | 1 | 1990 | 139 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 1992 | 290 | 0.020 |
Why?
|
| Models, Biological | 1 | 2013 | 677 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2009 | 21 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2009 | 35 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2009 | 69 | 0.020 |
Why?
|
| Caveolin 1 | 1 | 2009 | 29 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2009 | 195 | 0.020 |
Why?
|
| DNA Primers | 1 | 2009 | 286 | 0.020 |
Why?
|
| Mitochondria | 1 | 1992 | 487 | 0.020 |
Why?
|
| Aging | 1 | 2009 | 664 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 1371 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 1998 | 14 | 0.010 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 1998 | 28 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 40 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1998 | 77 | 0.010 |
Why?
|
| Protein Kinases | 1 | 1998 | 100 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1998 | 132 | 0.010 |
Why?
|
| Pregnancy | 2 | 1992 | 1549 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1998 | 239 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1992 | 111 | 0.010 |
Why?
|
| Placenta | 1 | 1992 | 97 | 0.010 |
Why?
|
| Glycerylphosphorylcholine | 1 | 1990 | 1 | 0.010 |
Why?
|
| Acrosin | 1 | 1990 | 2 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1990 | 20 | 0.010 |
Why?
|
| Sperm-Ovum Interactions | 1 | 1990 | 13 | 0.010 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 1990 | 20 | 0.010 |
Why?
|
| Acid Phosphatase | 1 | 1990 | 21 | 0.010 |
Why?
|
| Fructose | 1 | 1990 | 22 | 0.010 |
Why?
|
| Semen | 1 | 1990 | 51 | 0.010 |
Why?
|
| Rabbits | 1 | 1990 | 283 | 0.010 |
Why?
|
| Spermatozoa | 1 | 1990 | 200 | 0.000 |
Why?
|